glp-1 and afib Effects of Glucagon-Like Peptide-1 Receptor Agonists on Atrial Fibrillation Recurrence After Catheter Ablation GLP-1 Drugs Show Growing Promise

The active ingredient, semaglutide, binds to GLP-1 receptors in the pancreas and other tissues, triggering several beneficial effects

Eight serious adverse events, six in the exenatide and two in the placebo group, were recorded

222 Although limited direct evidence has evaluated use of GLP-1s with or without RDN-provided MNT, the SCALE, 13 STEP 1, 14 SURMOUNT, 15 and STEP 3 178 trials each demonstrated substantial weight reduction by combining GLP-1s with regular counseling sessions by RDNs or other qualified healthcare professionals (such lifestyle support was also provided to the placebo group in each trial)

This is my first article about a thematic ETF of this type

Losing 30 pounds but becoming weaker is not a good trade